Saturday, July 11, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “modified”

433 pharma patents match "modified" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 433
Index total 30,257
Page 16 / 19

Quick answer

This filtered view shows 433 pharmaceutical patents matching "modified" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

433 results for “modified” · 30,257 patents in full index Clear search

  1. US 7632932

    Oligonucleotides comprising a ligand tethered to a modified or non-natural nucleobase

    Alnylam Pharmaceuticals, Inc. · Granted Dec 15, 2009 · Expires Dec 10, 2029

    granted

  2. US 7632503

    Method of treating a muscle-related condition with modified IGF1 polypeptides

    REGENERON PHARMACEUTICALS, INC. · Granted Dec 15, 2009 · Expires Dec 10, 2029

    granted

  3. US 7622105

    Modified cytokines for use in cancer therapy

    FONDAZIONE CENTRO SAN RAFFAELE DEL MONTE TABOR · Granted Nov 24, 2009 · Expires Nov 19, 2029

    granted

  4. US 7622556

    Modified cytokines for use in cancer therapy

    FONDAZIONE CENTRO SAN RAFFAELE DEL MONTE TABOR · Granted Nov 24, 2009 · Expires Nov 19, 2029

    granted

  5. US 7612188

    Modified vitamin K. dependent polypeptides

    Regents of the University of Minnesota · Granted Nov 3, 2009 · Expires Oct 29, 2029

    granted

  6. US 7582744

    Chemically modified oligonucleotides

    Alnylam Pharmaceuticals, Inc. · Granted Sep 1, 2009 · Expires Aug 27, 2029

    granted

  7. US 7579451

    Oligonucleotides comprising a modified or non-natural nucleobase

    Alnylam Pharmaceuticals, Inc. · Granted Aug 25, 2009 · Expires Aug 20, 2029

    granted

  8. US 7576076

    Modified pyrimidine glucocorticoid receptor modulators

    Corcept Therapeutics Incorporated · Granted Aug 18, 2009 · Expires Aug 13, 2029

    granted

  9. US 7572764

    Uses of chemically-modified cholinesterases for detoxification of organophosporus compounds

    State of Israel, Prime Minister's Office, Israel Insitute For Biological Research · Granted Aug 11, 2009 · Expires Aug 6, 2029

    granted

  10. US 7553934

    Modified vitamin K-dependent polypeptides

    Regents of the University of Minnesota · Granted Jun 30, 2009 · Expires Jun 25, 2029

    granted

  11. US 7553653

    Variants and chemically-modified variants of phenylalanine ammonia-lyase

    BIOMARIN PHARMACEUTICAL INC. · Granted Jun 30, 2009 · Expires Jun 25, 2029

    granted

  12. US 7553935

    Modified vitamin K-dependent polypeptides

    Regents of the University of Minnesota · Granted Jun 30, 2009 · Expires Jun 25, 2029

    granted

  13. US 7524499

    Modified chimeric polypeptides with improved pharmacokinetic properties

    REGENERON PHARMACEUTICALS, INC. · Granted Apr 28, 2009 · Expires Apr 23, 2029

    granted

  14. US 7511015

    Modified defensins and their use

    The United States of America, as represented by the Department of Health and Human Services · Granted Mar 31, 2009 · Expires Mar 26, 2029

    granted

  15. US 7488804

    Modified fusion molecules for treatment of allergic disease

    The Regents of the University of California · Granted Feb 10, 2009 · Expires Feb 5, 2029

    granted

  16. US 7479551

    Modified vitamin K-dependent polypeptides

    Regents of the University of Minnesota · Granted Jan 20, 2009 · Expires Jan 15, 2029

    granted

  17. US 7476721

    Modified cytokines for use in cancer therapy

    FONDAZIONE CENTRO SAN RAFFAELE DEL MONTE TABOR · Granted Jan 13, 2009 · Expires Jan 8, 2029

    granted

  18. US 7374758

    Modified chimeric polypeptides with improved pharmacokinetic properties and methods of using thereof

    REGENERON PHARMACEUTICALS, INC. · Granted May 20, 2008 · Expires May 15, 2028

    granted

  19. US 7374757

    Modified chimeric polypeptides with improved pharmacokinetic properties

    REGENERON PHARMACEUTICALS, INC. · Granted May 20, 2008 · Expires May 15, 2028

    granted

  20. US 7355018

    Modified IGF1 polypeptides with increased stability and potency

    REGENERON PHARMACEUTICALS, INC. · Granted Apr 8, 2008 · Expires Apr 3, 2028

    granted

  21. US 7341726

    Modified HCV peptide immunogens

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 11, 2008 · Expires Mar 6, 2028

    granted

  22. US 7314917

    Modified vitamin K-dependent polypeptides

    Regents of the University of Minnesota · Granted Jan 1, 2008 · Expires Dec 27, 2027

    granted

  23. US 7309694

    Modified cytokines for use in cancer therapy

    FONDAZIONE CENTRO SAN RAFFAELE DEL MONTE TABOR · Granted Dec 18, 2007 · Expires Dec 13, 2027

    granted

  24. US 7303754

    MVA expressing modified HIV envelope, gag, and pol genes

    The Government of the United States of American, as represented by the Secretary, Department of Health and Human Services · Granted Dec 4, 2007 · Expires Nov 29, 2027

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.